Answers are grounded in this paper and cite their sources.
Mycobacterium abscessus is a highly drug-resistant nontuberculous mycobacterium (NTM). Efforts to discover new treatments for M. abscessus infections are accelerating, with a focus on cell wall synthesis proteins ( M. abscessus l , d -transpeptidases 1 to 5 [Ldt Mab1 to Ldt Mab5 ] and d , d -carboxypeptidase) that are targeted by β-lactam antibiotics.
No takes yet. Share an insight, caveat, or question.
Dousa et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: